Literature DB >> 8300246

Plasma fibronectin concentrations in patients with HIV infection and visceral leishmaniasis.

A Rodríguez-Cuartero1, J Nuñez-Carrill, A Salas-Galán, M A Rodríguez-Rodríguez.   

Abstract

Concentrations of circulating fibronectin were studied in plasma of 22 patients with acquired immunodeficiency syndrome and 24 healthy blood donors. There were significant differences between the plasma fibronectin values of the patient population with AIDS (mean 2 SD = 206 +/- 86 mg/l) and of the control group (mean +/- 2 SD = 297 +/- 92 mg/l). AIDS patients with visceral leishmaniasis showed a significant diminution of plasma fibronectin concentration (mean +/- 2 SD = 132 +/- 31 mg/l). A significant increase in plasma fibronectin concentrations was noted after 14 days of treatment with antimony (mean 2 SD = 239 +/- 67 mg/l). These results suggest that the measurement of fibronectin concentrations in patients with AIDS especially with concurrent infection, contributes to diagnosis. A significant decrease in plasma fibronectin concentrations was observed in patients with AIDS and visceral leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8300246     DOI: 10.1007/BF01712450

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  26 in total

1.  Plasma fibronectin is initially decreased during septicemia.

Authors:  T Ahlgren; L Berghem; C Jarstrand; L Lindquist
Journal:  Scand J Infect Dis       Date:  1985

2.  [Fibronectins: structure and function].

Authors:  M A Ouaissi; A Capron
Journal:  Ann Inst Pasteur Immunol (1985)       Date:  1985 Mar-Apr

3.  Fibronectin as an opsonic regulator of monocyte phagocytosis.

Authors:  A W Simpson; B J Boughton
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

Review 4.  Physiology of fibronectin.

Authors:  D F Mosher
Journal:  Annu Rev Med       Date:  1984       Impact factor: 13.739

5.  Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Relationship to extent of burn and development of sepsis.

Authors:  M E Lanser; T M Saba; W A Scovill
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

6.  Measurement of plasma fibronectin in patients who develop the adult respiratory distress syndrome.

Authors:  R J Maunder; J M Harlan; P E Pepe; S Paskell; C J Carrico; L D Hudson
Journal:  J Lab Clin Med       Date:  1984-10

7.  [Course of plasma fibronectin in burn patients. Its variations during septic episodes].

Authors:  J P Galizia; M D Besse; C Mazurier; X Gestermann; D Cantineau
Journal:  Ann Fr Anesth Reanim       Date:  1986

8.  Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.

Authors:  P D Smith; K Ohura; H Masur; H C Lane; A S Fauci; S M Wahl
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

9.  Fibronectin is produced by human macrophages.

Authors:  K Alitalo; T Hovi; A Vaheri
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

10.  Synthesis of fibronectin by cultured human endothelial cells.

Authors:  E A Jaffe; D F Mosher
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

View more
  3 in total

1.  Plasma fibronectin levels in patients with HIV-1 infection (Infection 22 [1994] 116)

Authors:  A Rodriguez-Cuartero; J Núñez-Carril
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

2.  Re: Rodriguez-Cuartero et al: plasma fibronectin levels in patients with HIV-1 infection (Infection 21 [1993] 303-305).

Authors:  D Torre; C Zeroli; M Giola; M Issi; R Martegani
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

3.  Levels of the circulating cell adhesion molecule E-selectin and disease progression in HIV infection.

Authors:  P P Sfikakis; V Tzavara; N Sipsas; O Kosmopoulou; P Sfikakis; T Kordossis
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.